Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sibutramine for weight loss in obese hypertensives
NCT00679653Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Feb 2002
- Primary completion
- Dec 2003
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of sibutramine in obesity, sponsored by Abbott Laboratories. Started Feb 2002; status: completed.
02
Drugs
sibutramine
03
Conditions
obesity
Beyond the preview
Go deeper on NCT00679653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00679653.